This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Rapid development of manufacturing processes for future production of adenovirus-vectored COVID19 vaccine at million-dose scale

The COVID-19 studies on our website have moved.

Please visit the list of nationally prioritised studies.